130 related articles for article (PubMed ID: 17276060)
1. Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: convergence of structure-based drug design and X-ray crystallographic study.
Yan S; Appleby T; Larson G; Wu JZ; Hamatake RK; Hong Z; Yao N
Bioorg Med Chem Lett; 2007 Apr; 17(7):1991-5. PubMed ID: 17276060
[TBL] [Abstract][Full Text] [Related]
2. 3-heterocyclyl quinolone inhibitors of the HCV NS5B polymerase.
Kumar DV; Rai R; Brameld KA; Riggs J; Somoza JR; Rajagopalan R; Janc JW; Xia YM; Ton TL; Hu H; Lehoux I; Ho JD; Young WB; Hart B; Green MJ
Bioorg Med Chem Lett; 2012 Jan; 22(1):300-4. PubMed ID: 22119470
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design of a novel thiazolone scaffold as HCV NS5B polymerase allosteric inhibitors.
Yan S; Appleby T; Larson G; Wu JZ; Hamatake R; Hong Z; Yao N
Bioorg Med Chem Lett; 2006 Nov; 16(22):5888-91. PubMed ID: 16934455
[TBL] [Abstract][Full Text] [Related]
4. Molecular design and synthesis of HCV inhibitors based on thiazolone scaffold.
Al-Ansary GH; Ismail MA; Abou El Ella DA; Eid S; Abouzid KA
Eur J Med Chem; 2013 Oct; 68():19-32. PubMed ID: 23933047
[TBL] [Abstract][Full Text] [Related]
5. Novel thiazolones as HCV NS5B polymerase allosteric inhibitors: Further designs, SAR, and X-ray complex structure.
Yan S; Larson G; Wu JZ; Appleby T; Ding Y; Hamatake R; Hong Z; Yao N
Bioorg Med Chem Lett; 2007 Jan; 17(1):63-7. PubMed ID: 17049849
[TBL] [Abstract][Full Text] [Related]
6. Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of thiazolone derivatives as hepatitis C virus NS5B polymerase allosteric inhibitors.
Lei B; Du J; Li S; Liu H; Ren Y; Yao X
J Comput Aided Mol Des; 2008 Oct; 22(10):711-25. PubMed ID: 18716715
[TBL] [Abstract][Full Text] [Related]
7. Effects of the aryl linker and the aromatic substituent on the anti-HCV activities of aryl diketoacid (ADK) analogues.
Kim J; Kim KS; Lee HS; Park KS; Park SY; Kang SY; Lee SJ; Park HS; Kim DE; Chong Y
Bioorg Med Chem Lett; 2008 Aug; 18(16):4661-5. PubMed ID: 18644717
[TBL] [Abstract][Full Text] [Related]
8. Discovery of substituted N-phenylbenzenesulphonamides as a novel class of non-nucleoside hepatitis C virus polymerase inhibitors.
May MM; Brohm D; Harrenga A; Marquardt T; Riedl B; Kreuter J; Zimmermann H; Ruebsamen-Schaeff H; Urban A
Antiviral Res; 2012 Aug; 95(2):182-91. PubMed ID: 22580131
[TBL] [Abstract][Full Text] [Related]
9. Tetrahydrobenzothiophene inhibitors of hepatitis C virus NS5B polymerase.
Laporte MG; Lessen TA; Leister L; Cebzanov D; Amparo E; Faust C; Ortlip D; Bailey TR; Nitz TJ; Chunduru SK; Young DC; Burns CJ
Bioorg Med Chem Lett; 2006 Jan; 16(1):100-3. PubMed ID: 16260131
[TBL] [Abstract][Full Text] [Related]
10. II. Novel HCV NS5B polymerase inhibitors: discovery of indole C2 acyl sulfonamides.
Anilkumar GN; Selyutin O; Rosenblum SB; Zeng Q; Jiang Y; Chan TY; Pu H; Wang L; Bennett F; Chen KX; Lesburg CA; Duca J; Gavalas S; Huang Y; Pinto P; Sannigrahi M; Velazquez F; Venkatraman S; Vibulbhan B; Agrawal S; Ferrari E; Jiang CK; Huang HC; Shih NY; George Njoroge F; Kozlowski JA
Bioorg Med Chem Lett; 2012 Jan; 22(1):713-7. PubMed ID: 22104146
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of thiazolone-based sulfonamides as inhibitors of HCV NS5B polymerase.
Ding Y; Smith KL; Varaprasad CV; Chang E; Alexander J; Yao N
Bioorg Med Chem Lett; 2007 Feb; 17(3):841-5. PubMed ID: 16990004
[TBL] [Abstract][Full Text] [Related]
12. 3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors.
Patel PD; Patel MR; Kaushik-Basu N; Talele TT
J Chem Inf Model; 2008 Jan; 48(1):42-55. PubMed ID: 18076152
[TBL] [Abstract][Full Text] [Related]
13. Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymerase.
Kim SH; Tran MT; Ruebsam F; Xiang AX; Ayida B; McGuire H; Ellis D; Blazel J; Tran CV; Murphy DE; Webber SE; Zhou Y; Shah AM; Tsan M; Showalter RE; Patel R; Gobbi A; LeBrun LA; Bartkowski DM; Nolan TG; Norris DA; Sergeeva MV; Kirkovsky L; Zhao Q; Han Q; Kissinger CR
Bioorg Med Chem Lett; 2008 Jul; 18(14):4181-5. PubMed ID: 18554907
[TBL] [Abstract][Full Text] [Related]
14. Non-nucleoside inhibitors of NS5B polymerase binding to allosteric sites: 3D- QSAR and molecular docking studies.
Cao H; Cao R; Zhang H; Zheng X; Gao D
Curr Med Chem; 2008; 15(15):1462-77. PubMed ID: 18537623
[TBL] [Abstract][Full Text] [Related]
15. Isothiazoles as active-site inhibitors of HCV NS5B polymerase.
Yan S; Appleby T; Gunic E; Shim JH; Tasu T; Kim H; Rong F; Chen H; Hamatake R; Wu JZ; Hong Z; Yao N
Bioorg Med Chem Lett; 2007 Jan; 17(1):28-33. PubMed ID: 17049853
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design of a benzodiazepine scaffold yields a potent allosteric inhibitor of hepatitis C NS5B RNA polymerase.
Vandyck K; Cummings MD; Nyanguile O; Boutton CW; Vendeville S; McGowan D; Devogelaere B; Amssoms K; Last S; Rombauts K; Tahri A; Lory P; Hu L; Beauchamp DA; Simmen K; Raboisson P
J Med Chem; 2009 Jul; 52(14):4099-102. PubMed ID: 19507864
[TBL] [Abstract][Full Text] [Related]
17. Tetracyclic indole inhibitors of hepatitis C virus NS5B-polymerase.
Stansfield I; Ercolani C; Mackay A; Conte I; Pompei M; Koch U; Gennari N; Giuliano C; Rowley M; Narjes F
Bioorg Med Chem Lett; 2009 Feb; 19(3):627-32. PubMed ID: 19131244
[TBL] [Abstract][Full Text] [Related]
18. Insight into the structural requirements of benzothiadiazine scaffold-based derivatives as hepatitis C virus NS5B polymerase inhibitors using 3D-QSAR, molecular docking and molecular dynamics.
Zhang HX; Li Y; Wang X; Xiao ZT; Wang YH
Curr Med Chem; 2011; 18(26):4019-28. PubMed ID: 21824089
[TBL] [Abstract][Full Text] [Related]
19. The discovery and structure-activity relationships of pyrano[3,4-b]indole-based inhibitors of hepatitis C virus NS5B polymerase.
Jackson RW; LaPorte MG; Herbertz T; Draper TL; Gaboury JA; Rippin SR; Patel R; Chunduru SK; Benetatos CA; Young DC; Burns CJ; Condon SM
Bioorg Med Chem Lett; 2011 Jun; 21(11):3227-31. PubMed ID: 21550237
[TBL] [Abstract][Full Text] [Related]
20. 1,5-Benzodiazepine inhibitors of HCV NS5B polymerase.
McGowan D; Nyanguile O; Cummings MD; Vendeville S; Vandyck K; Van den Broeck W; Boutton CW; De Bondt H; Quirynen L; Amssoms K; Bonfanti JF; Last S; Rombauts K; Tahri A; Hu L; Delouvroy F; Vermeiren K; Vandercruyssen G; Van der Helm L; Cleiren E; Mostmans W; Lory P; Pille G; Van Emelen K; Fanning G; Pauwels F; Lin TI; Simmen K; Raboisson P
Bioorg Med Chem Lett; 2009 May; 19(9):2492-6. PubMed ID: 19342234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
